Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

  • Allergy. 2020 Apr;75(4):940-942. doi: 10.1111/all.14035.
Luis A Pérez de Llano  1 ,  David Dacal Rivas  1 ,  Borja G Cosío  2  3
Affiliations
  • 1. Pneumology Service, Hospital Universitario Lucus Agusti, EOXI Lugo, Cervo, Monforte, Spain.
  • 2. Department of Respiratory Medicine, Hospital Universitario Son Espases-IdISBa, Palma de Mallorca, Mallorca, Spain.
  • 3. CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
PMID: 31483864 DOI: 10.1111/all.14035
Products